DAFTAR PUSTAKA

1. American Heart Association (AHA). Consensus- Based Decision-Making Processes.

www/heart.org.id/groups/heart. Diunduh 18 Oktober 2019.
2. Aronow WS. White coat hypertension. iMedPub Journals. 2015;1(1):6.
3. Artom N, Salvo F, Camardella F. White Coat Hypertension and Masked Hypertension:
An update. Italian Journal of Medicine. 2016;10:96- 102.
4. Burchell AE, Lobo MD, Sulke N, Sobotka PA, Paton JFR. Arteriovenous anastomosis.
Is this the way to control hypertension? Hypertension.2014;64:6-12.
5. Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb
CR, et al. Resistant Hypertension: Detection, evaluation, and management:A scientific
statement from the American Heart Association. Hypertension. 2018;72:53-90.
6. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016
ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal.
2016;37:2999-3058.
7. CobosB,ZolnierekKH,HowardK.Whitecoathyper tension:improingthepatient–health
care practitioner relationship. Psychol Res Behav Manag. 2015;8:133-41.
8. Cook J, van der Linden S, Maibach E, Lewandowsky S. The Consensus
Handbook.DOI:10.13021/G8MM6P. 2018.
9. Council of Europe. Developing a methodology for drawing up guidelines on best
medical practice. Recommendation Rec(2001)13 and explanatory memorandum.
Strasbourg: Council of Europe Publishing. 2002.
10. De Boeck K, Castellani C, Elborn JS. On behalf of the ECFS Board. Medical consensus,
guidelines, and position papers: A policy for the ECFS. Journal of Cystic Fibrosis.
2014;13:495–8.
11. De Rosa, M. Resistant hypertension: Definition, evaluation, and new therapeutic
approaches to treatment. Diseases and Disorders,1(1). 2017.
12. Grassi G. White-coat hypertension: not so innocent. E-Journal of Cardiology
Practice.2016;14(21).
13. Grassi G, Bombelli M, Buzzi S, Volpe M, Brambilla G. Neuroadrenergic disarray in
pseudo-resistant and resistant hypertension.Hypertension Research, 2014; 37(6):479-
83.
14. Grossman E. Ambulatory Blood Pressure Monitoring in the Diagnosis and
Management of Hypertension. Diabetes Care. 2013; 36(S2):307–11.
15. Guidelines JSH 2009 Chapter 12. Secondary hypertension. Hypertension Research.
2009;32:78–90.
16. Judd E, Calhoun D. Apparent and true resistant hypertension: definition, prevalence
and outcomes. Journal of Human Hypertension.2014; 28(8),463-8.
17. Kario K, Park S, Buranakitjaroen P, Chia YC, Chen CH, Divinagracia R, et al.
Guidance on home blood pressure monitoring: A statement of the HOPE Asia Network.
J Clin Hypertens (Greenwich). 2018;20(3):456-61.
18. Kario K, Chen CH, Park S, Park CG, Hoshide S, Cheng HM, Huang QF, Wang JG.
Consensus document on improving hypertension management in Asian patients, taking
into account Asian characteristics. Hypertension. 2018;71:375–382. doi:
10.1161/HYPERTENSIONAHA.117.10238.
19. Konsensus Penatalaksanaan Hipertensi 2019.Perhimpunan Dokter Hipertensi
Indonesia. Jakarta : Indonesian Society of Hypertension.2019
20. Infodatin.Pusat Data dan Informasi Kementerian Kesehatan Indonesia. Hipertensi.
Jakarta :pusat data dan informasi kementerian Kesehatan RI
21. Weber,M.A, Schiffrin et al. Clinical practice guidelines for the management of
hypertension in the community : a statement by the American society of hypertension
and the international society of hypertension. Journal of clinical hypertension.2014;14-
26
22. World Health Organization (WHO). A Global Brief on Hypertension: Silent Killer,
Global Public Health Crisis [Internet]. 2013 [diakses pada 12 Oktober 2019]. Tersedia
dari: http://chronicconditions.thehealthwell.info/search-results/global-brief-
hypertension-silent-killer-global-public-health-crisis?source=relatedblock
23. ACC/AHA. Guideline fo the Prevention, Detection, Evaluation and Management of
High Blood Pressure in Adult. 2017.
24. Krishnan A, Garg R, Kahandaliyanage A. Hypertension in the South-East Asia Region:
an overview. Regional Health Forum. 2013; 17(1): 7-14.
25. James PA, Oparil S, Carter BL et al. 2014 Evidence-Based Guideline for the
Management of High Blood Pressure in Adults Report From the Panel Members
Appointed to the Eighth Joint National Committee (JNC 8). JAMA: 2013. 10:284-427.
26. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh
Report of the Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206–52.
27. Sudoyo, dkk. Buku Ajar Ilmu Penyakit Dalam. Jakarta: Interna Publishing. 2009.
28. Keyne, Angelina, Hipertensi Menurut JNC VIII. [referat] Jakarta: Universitas Atma
Jaya. 2014
29. Konsensus Hipertensi InaSH 2013. Available: www.drivehq.com/folder/p10733490/
11314349336.aspx. Accesed on 12 Oktober 2018.
30. Perhimpunan Hipertensi Indonesia. Ringkasan Eksekutif Krisis Hipertensi 2008.
Jakarta: INA SH
31. Organization WH. A global brief on Hypertension: silent killer, global public health
crises (World Health Day 2013). Geneva: WHO. 2013
32. Whelton PK, Carey RM, AronowWS, CaseyJr DE, Collins KJ, Himmelfarb CD, et al.
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA
Guideline for the Prevention, Detection, Evaluation, and Management of High Blood
Pressure in Adults: Executive Summary: A Report of the American College of
Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Hypertension.2018;71:1269-1324.